ArticleMilitary Medical Research2025

Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis.

Wei-Qiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.